Skip to main content
. 2024 Aug 30;38(11):6356–6367. doi: 10.1007/s00464-024-11220-z

Table 2.

Survival rate of patients with colorectal neuroendocrine tumors in the ET group and SR group

ET group SR group P-value
Overall survival rate before PSM(%)
 1-year 97.3 87.5  < 0.001
 3-year 92.2 75.5  < 0.001
 5-year 85.2 55.5  < 0.001
Overall survival rate after PSM(%)
 1-year 97.1 88.6  < 0.001
 3-year 89.6 77.6  < 0.001
 5-year 77.4 57.5  < 0.001
Cancer specific survival rate before PSM(%)
 1-year 99.5 93.5  < 0.001
 3-year 98.8 88.0  < 0.001
 5-year 97.9 77.3  < 0.001
Cancer specific survival rate after PSM(%)
 1-year 99.3 94.4  < 0.001
 3-year 98.2 89.8  < 0.001
 5-year 96.5 80.2  < 0.001

ET endoscopic therapy, SR surgical resection, PSM propensity score matching

Bold values indicate P < 0.05